Lifeway Foods, Inc.
LWAYConsumer DefensiveNASDAQPackaged Foods
Scan Results
Daily timeframeLifeway Foods, Inc. produces and markets probiotic-based products in North America. The company carries a $364.2M market cap, placing it firmly in the small-cap category. The company's primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and milk types.
Market Cap
$364.2M
Beta
0.53
P/E (TTM)
24.82
P/E (Fwd)
17.39
EPS (TTM)
$0.96
EPS (Fwd)
$1.37
ROE
18.2%
ROA
12.2%
Cash
$5.6M
Total Debt
$7.5M
Free CF
-$22.6M
52W Change
-0.1%
Annual Financials
Cash vs Debt
On the balance sheet, LWAY has $5.6M in cash with $7.5M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow is running at -$22.6M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at 18.2%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 12.2% further supports the picture of efficient asset utilization. Revenue has grown from $141.6M (2022) to $212.5M (2025), reflecting a 50% increase over the period.
With a beta below 0.7, Lifeway Foods, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. No single metric tells the full story. Reviewing LWAY's risk profile alongside its fundamentals and technical indicators provides a more complete picture.